ArticleEuropean journal of medical research2022

Protective effect of Secukinumab on severe sepsis model rats by neutralizing IL-17A to inhibit IKBα/NFκB inflammatory signal pathway.

Xingsheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.